Nationwide protests took place as questions remain after border czar Tom Homan announced earlier he ordered federal immigration authorities to work on a drawdown plan for Minnesota.

Performances in N.Y.C. Advertisement Supported by Recent works by Gabriela Ortiz, choral music by David Lang and unreleased recordings by Radu Lupu are among our selections. Los Angeles Philharmonic; ...

COLUMBUS, Ohio (WCMH) — When you go to a brand-new Columbus Metropolitan Library (CML) branch, you’ll notice it’s not just the usual giant rows of books as you’d expect. The changes are intentional, ...

With the combination of asciminib plus a TKI, 91% of CML patients had attained a major molecular response by month 36. Combining asciminib, a first-in-class BCL::ABL1 inhibitor, with a tyrosine kinase ...

Earlier this year, Spotify rolled out an all-new feature that lets users watch music videos within the app. You can switch between audio and video formats with the new feature, which is slowly being ...

Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival. When imatinib (Gleevec; Novartis), the first-ever tyrosine kinase inhibitor, made its ...

AI-generated bands like The Velvet Sundown are going viral on streaming platforms. "[The Velvet Sundown]" is much better music than most of what we've heard from AI in the past," Jason Palamara, a ...

Chronic myeloid leukemia (CML) is a hematopoietic malignancy characterized by BCR-ABL1 gene fusion. The immune microenvironment, implicated in relapse and drug resistance, poses significant challenges ...

Asciminib, a first-in-class BCR-ABL1 TKI, showed high molecular response rates and was well tolerated in the first prospective trial of its kind evaluating the drug as a dose-escalated second-line ...

The choice of frontline therapy for a patient with chronic phase chronic myeloid leukemia (CP-CML) can have a profound effect on the long-term clinical outcome. Currently, five tyrosine kinase ...